Reach Us +447482877761
Reviewer - Gerd Bobe | Linus Pauling Institute Oregon State Univer | 1848
ISSN: 2157-7579

Journal of Veterinary Science & Technology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

15th International Veterinary Congress

Paris, France

Asia Pacific Veterinary Congress

Singapore, Singapore

8th International Conference on Parasitology & Microbes

Singapore, Singapore
Share This Page

Gerd Bobe

Principal Investigator, Linus Pauling Institute Assistant Professor, Department of Animal Sciences


M.P.H. Public Health Nutrition, Johns Hopkins Bloomberg School of Public Health, 2006 Ph.D. Animal Nutrition, Iowa State University, 2002 M.S. Nutritional Physiology and Animal Breeding, Iowa State University, 1997 I accept graduate students for Animal and Rangeland Sciences

Research Interest

This laboratory focuses on identifying biomarkers in humans and parallel animal models that are associated with colorectal and pancreatic cancer and can be modified by diet and dietary supplements, including micronutrients and polyphenols. Colorectal cancer is an important public health problem annually leading worldwide to over 0.5 million deaths and in the U.S. nearly 150,000 new cases and 50,000 deaths. Dietary change, both feasible and safe, represents a viable strategy for preventing colorectal cancer; however, dietary intervention trials often showed no protection. There is a need for biomarkers of exposure, risk, and response/efficacy to dietary interventions. Such biomarkers will provide crucial data to a) identify individuals at increased risk or early stages of colorectal carcinogenesis, b) measure compliance with dietary interventions, and c) predict individuals most likely to benefit from a long-term dietary intervention (i.e., personalized cancer prevention). In collaborations with researchers at the National Cancer Institute, Pennsylvania State University, Ohio State University, Texas A&M University, and Tufts, we have been using prospective NCI-funded human cohort and nutrition studies and link them to USDA and Tufts food data bases to identify diets and dietary components with promise of efficacious cancer prevention, most notable flavonols. For dietary components showing efficacy, we have been identifying biomarkers of exposure, risk, and early dietary response through parallel human intervention and animal model studies in serum, feces, and tissue, most notable interleukin 6. The functional significance of the identified molecular targets in carcinogenesis will be tested using cell culture and transgenic mouse studies. The goal is to use the identified molecular targets and biomarkers in clinical trials to test the efficacy of diets and dietary supplements for cancer prevention.

Global Speakers in the subject

Global Experts in the subject